Overview

Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries

Status:
NOT_YET_RECRUITING
Trial end date:
2026-07-30
Target enrollment:
Participant gender:
Summary
This prospective randomized controlled study will be conducted to evaluate the effect of preoperative single, micro-dose of dexmedetomidine (0.3g/kg) on the incidence and severity of EA in adults undergoing Septoplasty surgeries
Phase:
NA
Details
Lead Sponsor:
Tanta University
Treatments:
Dexmedetomidine
Sodium Chloride